Source: http://legislature.maine.gov/statutes/22/title22sec2423-F-1.html
Timestamp: 2020-07-04 00:13:52
Document Index: 62054657

Matched Legal Cases: ['§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§17', '§15', '§9', '§17']

A person may not manufacture marijuana products or marijuana concentrate or engage in marijuana extraction except as provided in this chapter. [PL 2019, c. 331, §17 (RPR).]
[PL 2019, c. 331, §17 (RPR).]
A person that intends to engage in marijuana extraction using inherently hazardous substances shall notify the department of that intention prior to engaging in marijuana extraction using inherently hazardous substances. The department may deny an application of a person authorized under this paragraph to register pursuant to rules adopted under subsection 10 if the person did not notify the department in accordance with this paragraph. [PL 2019, c. 331, §17 (RPR).]
B. A person that is not a qualifying patient, caregiver or dispensary and that meets the requirements of a person authorized under paragraph A, pays the fee required by section 2425‑A, subsection 10 and meets the requirements of rules adopted under subsection 10 is authorized to engage in marijuana extraction using inherently hazardous substances and may possess up to 40 pounds of harvested marijuana in accordance with subsection 5. [PL 2019, c. 331, §17 (RPR).]
A. May manufacture marijuana products and marijuana concentrate for medical use using any method that does not involve an inherently hazardous substance, except that a registered manufacturing facility may manufacture marijuana concentrate using inherently hazardous substances if authorized under subsection 3; [PL 2019, c. 331, §17 (RPR).]
B. May obtain harvested marijuana from a qualifying patient, a caregiver or a registered dispensary and may transfer marijuana products and marijuana concentrate to the person that provided the harvested marijuana used to manufacture the marijuana product or marijuana concentrate; [PL 2019, c. 331, §17 (RPR).]
C. May transfer samples to a marijuana testing facility for testing; [PL 2019, c. 331, §17 (RPR).]
D. May conduct testing of marijuana products or marijuana concentrate manufactured by the facility for research and development purposes; [PL 2019, c. 331, §17 (RPR).]
E. May receive reasonable compensation for manufacturing marijuana products or marijuana concentrate; [PL 2019, c. 331, §17 (RPR).]
F. Shall dispose of harvested marijuana used in the manufacturing process in a manner that prevents its diversion to persons not authorized to possess harvested marijuana possessed by the facility and in accordance with rules adopted by the department; and [PL 2019, c. 331, §17 (RPR).]
G. May hire any number of assistants to assist in performing the duties of the manufacturing facility. [PL 2019, c. 331, §17 (RPR).]
A. May engage in marijuana extraction to produce marijuana concentrate for medical use; [PL 2019, c. 331, §17 (RPR).]
B. May obtain harvested marijuana from a qualifying patient, a caregiver or a dispensary and may transfer marijuana concentrate to the person that provided the harvested marijuana used to produce the marijuana concentrate; [PL 2019, c. 331, §17 (RPR).]
D. May conduct testing of marijuana concentrate produced by the person for research and development purposes; [PL 2019, c. 331, §17 (RPR).]
E. May receive reasonable compensation for producing marijuana concentrate; [PL 2019, c. 331, §17 (RPR).]
F. Shall dispose of harvested marijuana used in the extraction process in a manner that prevents its diversion to persons not authorized to possess harvested marijuana possessed by the person and in accordance with rules adopted by the department; and [PL 2019, c. 331, §17 (RPR).]
G. May hire any number of assistants to assist in performing the activities authorized under this subsection, except that a qualifying patient authorized under subsection 3 may not hire an assistant. [PL 2019, c. 331, §17 (RPR).]
(1) The annual fee required pursuant to section 2425‑A, subsection 10;
(4) The name, address and date of birth of each officer or director of the facility or person. [PL 2019, c. 331, §17 (RPR).]
If the department determines not to issue a registry identification card for a person, officer or director or assistant, the department shall notify the registered manufacturing facility or person authorized to engage in marijuana extraction using inherently hazardous substances in writing of the reason for denying the registry identification card. [PL 2019, c. 331, §17 (RPR).]
A. The registry identification number of the manufacturing facility; [PL 2019, c. 331, §17 (RPR).]
B. Information that allows the provider of the marijuana to the manufacturing facility to confirm that the marijuana provided was used to manufacture the marijuana product or marijuana concentrate transferred back to that provider; [PL 2019, c. 331, §17 (RPR).]
C. Ingredients other than material derived from marijuana plants contained in the marijuana product or marijuana concentrate; and [PL 2019, c. 331, §17 (RPR).]
D. Any chemicals, solvents or other substances used to manufacture the marijuana product or marijuana concentrate. [PL 2019, c. 331, §17 (RPR).]
10. Rulemaking. The department shall adopt routine technical rules as defined in Title 5, chapter 375, subchapter 2‑A governing manufacturing facilities, including but not limited to:
A. Requirements for the registration of a manufacturing facility and an officer or director or assistant of a registered manufacturing facility; [PL 2019, c. 331, §17 (RPR).]
B. Requirements for engaging in marijuana extraction using inherently hazardous substances; [PL 2019, c. 331, §17 (RPR).]
C. Manufacturing facility officer or director qualification requirements; [PL 2019, c. 331, §17 (RPR).]
D. Required security for manufacturing facilities; [PL 2019, c. 331, §17 (RPR).]
E. Requirements of a disposal plan for harvested marijuana used in the manufacturing process; and [PL 2019, c. 331, §17 (RPR).]
F. Minimum record-keeping requirements, including an annual audit requirement. [PL 2019, c. 331, §17 (RPR).]
G. [PL 2019, c. 331, §17 (RP).]
11. Multiple authorizations. A manufacturing facility or person registered pursuant to subsection 8 may also be a qualifying patient, a caregiver or a registered dispensary. A manufacturing facility or person authorized to possess marijuana under this chapter may possess the amount allowed for that manufacturing facility or person in addition to the possession amount allowed under this section if the manufacturing facility or person is registered pursuant to this section. The marijuana possessed must be distinguishable with respect to the purposes for which it is authorized to be possessed.
12. Record keeping. A registered manufacturing facility or person authorized to engage in marijuana extraction using inherently hazardous substances under subsection 3 shall maintain records of all transactions in accordance with section 2430‑G.
13. Colocation of facilities. A manufacturing facility that is also licensed as an adult use marijuana products manufacturing facility under Title 28‑B, chapter 1 may manufacture marijuana products and marijuana concentrate for adult use within the same facility in which the licensee also manufactures marijuana products or marijuana concentrate for medical use pursuant to this chapter. The following items or areas within the shared facility may be shared for both manufacturing pursuant to this chapter and pursuant to Title 28‑B, chapter 1:
A. Manufacturing-related and nonmanufacturing-related equipment, except that manufacturing-related equipment may not be simultaneously used for manufacturing pursuant to this chapter and pursuant to Title 28-B, chapter 1; [PL 2019, c. 331, §17 (RPR).]
B. Manufacturing-related and nonmanufacturing-related supplies or products not containing harvested marijuana and the storage areas for those supplies or products; and [PL 2019, c. 331, §17 (RPR).]
C. General office space, bathrooms, entryways and walkways. [PL 2019, c. 331, §17 (RPR).]
14. Immunity.
A. [PL 2019, c. 331, §17 (RP).]
B. [PL 2019, c. 331, §17 (RP).]
[PL 2019, c. 331, §17 (RP).]
PL 2017, c. 447, §15 (NEW). PL 2017, c. 452, §9 (NEW). PL 2019, c. 331, §17 (RPR).